Nocturnal nasal postive pressure ventilation plus oxygen therapy versus oxygen alone in severe stable chronic obstructive pulmonary disease

ISRCTN ISRCTN24818612
DOI https://doi.org/10.1186/ISRCTN24818612
Protocol serial number 921019
Sponsor Hong Kong Health Services Research Fund (Hong Kong)
Funder Hong Kong Health Services Research Fund (Hong Kong)
Submission date
10/10/2002
Registration date
10/10/2002
Last edited
01/07/2009
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Respiratory
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr DSC Hui
Scientific

Department of Medicine & Therapeutics
Prince of Wales Hospital
Chinese University of Hong Kong
-
-
Hong Kong

Study information

Primary study designInterventional
Study designRandomised controlled trial
Secondary study designRandomised controlled trial
Scientific title
Study objectivesNot provided at time of registration
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedRespiratory diseases
InterventionPatients will then be randomized into two groups receiving:
1. Non-invasive positive pressure ventilation (NPPV) plus LTOT, or
2. LTOT plus oral placebo over a 3-month period.

NPPV will be delivered via a portable bilevel positive airway pressure (BiPAP) Duet device via a nasal or oral-nasal mask.
Intervention typeDrug
PhaseNot Specified
Drug / device / biological / vaccine name(s)oxygen
Primary outcome measure(s)

Not provided at time of registration

Key secondary outcome measure(s)

Not provided at time of registration

Completion date31/12/2002

Eligibility

Participant type(s)Patient
Age groupNot Specified
SexNot Specified
Key inclusion criteriaPatients with severe stable chronic obstructive pulmonary disease with hypercapnic respiratory failure already on domiciliary long-term oxygen therapy (LTOT)
Key exclusion criteriaDoes not meet inclusion criteria
Date of first enrolment01/01/2002
Date of final enrolment31/12/2002

Locations

Countries of recruitment

  • China
  • Hong Kong

Study participating centre

Department of Medicine & Therapeutics
-
-
Hong Kong

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
IPD sharing plan